Skip to main content
PLOS One logoLink to PLOS One
. 2026 Feb 12;21(2):e0342732. doi: 10.1371/journal.pone.0342732

Expression of Concern: Targeting NLRP3 and AIM2 signaling pathways by Viscosol alleviates metabolic dysregulations induced inflammatory responses in diabetic neuro- and nephropathy: An in silico and in vivo study

The PLOS One Editors
PMCID: PMC12900287  PMID: 41678448

After this article [1,2] was published, concerns were raised that the article cited as Reference 9 was retracted before publication of [1,2]. Additionally, the PLOS One Editors have concerns about the article’s compliance with the PLOS Authorship policy.

In light of the cumulative issues, the PLOS One Editors issue this Expression of Concern. Readers are advised to interpret the article [1,2] with caution.

References

  • 1.Thahiem S, Ihsan M, Muneer H, Sohail A, Khan M, Murtaza I, et al. Targeting NLRP3 and AIM2 signaling pathways by Viscosol alleviates metabolic dysregulations induced inflammatory responses in diabetic neuro- and nephropathy: An in silico and in vivo study. PLoS One. 2025;20(4):e0313816. doi: 10.1371/journal.pone.0313816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Thahiem S, Ihsan M, Muneer H, Sohail A, Khan M, Murtaza I, et al. Correction: Targeting NLRP3 and AIM2 signaling pathways by Viscosol alleviates metabolic dysregulations induced inflammatory responses in diabetic neuro- and nephropathy: An in silico and in vivo study. PLoS One. 2025;20(12):e0338855. doi: 10.1371/journal.pone.0338855 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLOS One are provided here courtesy of PLOS

RESOURCES